title: The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects.
abstract: Fourteen subjects are described in whom a clinical diagnosis of the delayed sleep phase syndrome was made. The condition is multi-factorial, dependent on lifestyle, mood and personality, as well as on familial factors but no single factor in isolation is sufficient to explain the delay in sleep timing. Refusal to attend school may be important in some instances but will not explain cases with delayed age of onset. In half the subjects the delay in sleep phase started in childhood or adolescence. The syndrome causes severe disruption to education, work and family life. Polysomnography, motor activity monitoring of rest-activity cycles, plasma melatonin profiles and urinary melatonin metabolite excretion are normal. Different patterns of sleep phase delay seen in the syndrome include stable, progressive, irregular and non-24 hour sleep-wake cycles. These patterns may result from different social and other Zeitgebers ("time-markers", for example sunrise, sunset) in the normal environment. Treatment by forced sleep-wake phase advance or with melatonin resulted in a partial sleep-phase advance but this was not maintained on stopping treatment.
authors.affiliation: University Department of Neurology, King's College Hospital, London, UK.
authors.forename: B
authors.initials: B
authors.lastname: Alvarez
authors.forename: M J
authors.initials: MJ
authors.lastname: Dahlitz
authors.forename: J
authors.initials: J
authors.lastname: Vignau
authors.forename: J D
authors.initials: JD
authors.lastname: Parkes
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001521:Behavior Therapy; D002385:Cataplexy / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D002940:Circadian Rhythm / Q000187:drug effects; D003131:Combined Modality Therapy; D005260:Female; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D008297:Male; D008550:Melatonin / Q000627:therapeutic use; D008875:Middle Aged; D009290:Narcolepsy / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D012893:Sleep Wake Disorders / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D012931:Social Environment; D013577:Syndrome; D014851:Wakefulness / Q000187:drug effects
chemical_list: D006680:HLA Antigens; D008550:Melatonin